TY  - JOUR
AU  - Sancho, Juan-Manuel
AU  - Marin-Niebla, Ana
AU  - Fernandez, Silvia
AU  - Capote, Francisco-Javier
AU  - Cañigral, Carolina
AU  - Grande, Carlos
AU  - Donato, Eva
AU  - Zeberio, Izaskun
AU  - Puerta, Jose-Manuel
AU  - Rivas, Alfredo
AU  - Perez-Ceballos, Elena
AU  - Vale, Ana
AU  - Martin Garcia-Sancho, Alejandro
AU  - Salar, Antonio
AU  - Gonzalez-Barca, Eva
AU  - Teruel, Anabel
AU  - Pastoriza, Carmen
AU  - Conde-Royo, Diego
AU  - Sanchez-Garcia, Joaquin
AU  - Barrenetxea, Cristina
AU  - Arranz, Reyes
AU  - Hernandez-Rivas, Jose-Angel
AU  - Ramirez, Maria-Jose
AU  - Jimenez, Aroa
AU  - Rubio-Azpeitia, Eva
PY  - 2022
DO  - 10.1007/s12185-022-03367-z
UR  - http://hdl.handle.net/10668/21263
T2  - International journal of hematology
AB  - This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6%...
LA  - en
PB  - Springer
KW  - Clinical practice
KW  - Ibrutinib
KW  - Mantle-cell lymphoma
KW  - Real-world evidence
KW  - Relapsed/refractory
KW  - Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
KW  - Adenine
KW  - Adult
KW  - Humans
KW  - Lymphoma, mantle-cell
KW  - Middle aged
KW  - Neoplasm recurrence, local
KW  - Piperidines
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Retrospective studies
TI  - IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
TY  - research article
VL  - 116
ER  -